Rosuvastatin Calcium Tablet
Product Images NDC 68788-8775

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68788-8775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin Calcium Tablets 10mg (Rosuvastatin Tablets 10mg 90s Bottle Label)

Rosuvastatin Calcium Tablets 10mg (Rosuvastatin Tablets 10mg 90s Bottle Label)
Rosuvastatin Calcium Tablets 10 mg label from Preferred Pharmaceuticals Inc. The label includes the drug name, strength, and form (film-coated tablet), along with generic reference to Crestor. It shows storage and handling information, manufacturer Umedica Laboratories Pvt. Ltd., and caution about prescription use. The label contains space for dosage directions in English and Spanish with placeholders for quantity, lot, and batch numbers.*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
A Kaplan-Meier cumulative incidence plot comparing Rosuvastatin Calcium (Rosuva) versus placebo over approximately 5 years. The graph shows cumulative incidence (%) on the y-axis and years on the x-axis. The Rosuvastatin group exhibits a lower cumulative incidence than placebo, with hazard ratio and confidence interval noted, alongside numbers at risk for both groups at specified time points.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
A data table presenting clinical event rates comparing Rosuvastatin Calcium 20 mg and placebo 20 mg groups. It shows the number of events, hazard ratios with 95% confidence intervals, and p-values for endpoints such as primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A forest plot visualizes the hazard ratios and confidence intervals.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
A box plot chart comparing the percent change from baseline in LDL-C for four drugs: CRESTOR, Atorvastatin, Simvastatin, and Pravastatin, at various doses (10, 20, 40, and 80 mg where applicable). The vertical axis shows percent change, ranging roughly from 0 to -75%.*
FDA Label Image
FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Structural_formula (Rosuvastatin Tablets Structure)
Chemical structure of Rosuvastatin Calcium, showing its molecular arrangement including fluorophenyl and sulfonyl moieties, with calcium ions represented as Ca2+.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.